PATENT CLAIM ANALYSIS

Application Number: 16239265
Application Type: Utility
Filing Date: 2019-01
Publication Date: 2019-05
Patent Classification: ["514", "428000"]

Abstract:
The invention relates to compounds of formula I: where a, R 1 , and R 3-6  are as defined in the specification, or a pharmaceutically acceptable salt thereof. The compounds of formula I are serotonin and norepinephrine reuptake inhibitors. The invention also relates to pharmaceutical compositions comprising such compounds; methods of using such compounds; and process and intermediates for preparing such compounds.

Claim (Index 43):
The pharmaceutical composition of  claim 38 , wherein the pharmaceutical composition contains about 1 milligram to about 20 milligrams of the compound or a pharmaceutically acceptable salt thereof.

Metadata:
- Claim Count in Document: 2.0
- Percentile: 99.0
- Lexical Diversity: 1.59091
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15591419', '14848933', '12617821', '16007233', '13631192']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8072823394210613
- 35 USC 102 Novelty (BERT): 0.5331635191985192
- Combined Prediction Score: 0.7798704573988071
- Mean Citation Score: 349.845176
- Max Citation Score: 365.36838
- Similarity Product: 303.59720111583715

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test